Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2006 | 12-2005 | |
| Sales | 1,470 | 0 | 0 |
| Gross Profit | 1,470 | N/A | N/A |
| Operating Expenses | 7,739 | 0 | 0 |
| Operating Income | -6,269 | N/A | N/A |
| Interest Expense | 1 | 0 | 0 |
| Other Income | 8 | 0 | 0 |
| Pre-tax Income | -6,263 | 0 | 0 |
| Net Income Continuous | -6,263 | N/A | N/A |
| Net Income | $-6,263 | $N/A | $N/A |
| EPS Basic Total Ops | -42.60 | N/A | N/A |
| EPS Basic Continuous Ops | -38.00 | N/A | N/A |
| EPS Diluted Total Ops | -42.60 | N/A | N/A |
| EPS Diluted Continuous Ops | -38.00 | N/A | N/A |
| EBITDA(a) | $-6,154 | $N/A | $N/A |